Targeted disruption of the Runx1/ AML1 gene in mice has demonstrated that it is required for the emergence of definitive hematopoietic cells, but that it is not essential for the formation of primitive erythrocytes. These findings led to the conclusion that Runx1 is a stage-specific transcription factor acting only during definitive hematopoiesis. However, the zebrafish and Xenopus homologues of Runx1 have been shown to play roles in primitive hematopoiesis, suggesting that mouse Runx1 might also be involved in the development of primitive lineages. In this study, we show that primitive erythrocytes in Runx1 -/-mice display abnormal morphology and reduced expression of Ter119, Erythroid Kruppel-like factor (EKLF, KLF1), and GATA-1. These results suggest that mouse Runx1 plays a role in the development of both primitive and definitive hematopoietic cells.
Introduction
Recent studies have revealed that the process of hematopoiesis is largely conserved in vertebrates. During development, similar sequential waves of primitive and definitive hematopoiesis are observed in mammals, fish, and amphibians. [1] [2] [3] In the mouse embryo, primitive erythrocytes first appear in the yolk sac blood island at embryonic day (E) 7 and lead to the production of nucleated erythrocytes. 4, 5 These erythrocytes (erythroblasts) start to circulate at 4 to 6 somite pairs (E8.25) 6 and are necessary for the survival of the embryo before establishment of definitive erythropoiesis, which is initiated in the fetal liver around E12 and is characterized by the production of enucleated erythrocytes. 4 The equivalent site of blood island in zebrafish embryo is known as the intermediate cell mass (ICM), which is located in the posterior part of embryo and provides the primitive erythrocytes.
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Runx1/AML1 encodes the DNA-binding subunit of the Runt domain transcription factor, 7 which plays crucial roles in processes of organ and tumor development, such as hematopoiesis, neural development, and leukemogenesis. 8, 9 Runx1-deficient mice die around E12.5 due to severe hemorrhaging in the central nervous system (CNS) and a complete lack of definitive hematopoietic cells, including the aortic hematopoietic clusters, which are thought to comprise hematopoietic stem cells. [10] [11] [12] [13] [14] The specification of definitive hematopoietic stem cells by Runx1 has also been observed in the zebrafish embryo. Depletion of zebrafish Runx1 by antisense 4 morpholino oligonucleotides leads to a severe defect in definitive hematopoietic development in the dorsal aorta. 15, 16 Although Runx1 has been implicated in primitive hematopoiesis in zebrafish and
Xenopus embryos, 15, 17 its function during primitive erythropoiesis in the mouse has not been described despite its reported expression in this lineage. 13, 18 In this study, we examined primitive erythrocytes in Runx1 -/-mice and observed aberrant morphology and reduced expression of Ter119, Erythroid Kruppel-like factor (EKLF, KLF1), and GATA-1, in these cells.
Materials & Methods

Mice
Runx1-deficient mice (C57BL/6) have been previously described. 12 For visualizing GATA-1 expression in primitive erythrocytes, IE3.9-LacZ transgenic mice carrying a 3.9 kb GATA-1 promoter-LacZ reporter gene (C57BL/6 x DBA/2 mixed background) 19 were crossed with Runx1-deficient mice. For the transgenic complementary rescue experiment, G1-HRD-Runx1 transgenic mice carrying a 8.0 kb GATA-1 hematopoietic regulatory domain -Runx1 transgene (C57BL/6 x DBA/2 mixed background) 20 were crossed with Runx1-deficient mice.
Benzidine-and LacZ-staining
Embryos were fixed at 4 o C for 2 hours in 1% formaldehyde, 0.2% glutaraldehyde, and 0.02% Nonidet P-40 in PBS. For LacZ-staining, embryos were incubated at 37 o C overnight in 2 mM MgCl 2 , 5 mM K 3 Fe(CN) 6 , 5 mM K 4 Fe(CN) 6 , and 1 mg/ml X-Gal in PBS. For Benzidine-staining, embryos were incubated for 15 min in 14% Benzidine base (3% Benzidine in 90% glacial acetic acid/10% H 2 0) and 14% H 2 O 2 in H 2 O.
Scanning Electron Microscopy
Peripheral blood cells from E12.5 embryos were fixed with 1.6% glutaraldehyde, postfixed in 1% osmium tetraoxide. After dehydration with a graded series of alcohol 6 solutions, the samples were freeze-dried, coated with a layer of gold and observed under a scanning electron microscope (JEOL, JSM-6320F).
In vitro hematopoietic progenitor assay
A colony assay for the development of primitive erythroid lineages was performed as described. 21 Briefly, E8.5 whole embryos from each genotypes were treated with trypsin (Invitrogen) for 5min at 37 , and washed with PBS containing 5% FBS. The cells were plated in 1% methylcellulose/IMDM supplemented with 10% Plasma derived serum (PDS), 5% Protein free hybridoma medium (PFHM) (Invitrogen), 12.5 mg/ml ascorbic acid (Wako), 2 mM L-glutamine, 10 mg/ml transferring (Boehringer Manheim), 39 ng/ml MTG (Sigma), 5 ng/ml stem cell factor (R&D systems), 50 ng/ml erythropoietin. After 3 days of culture, primitive erythroid colonies were counted.
Cell preparation and staining
Embryos were treated with Dispase II (Roche) and cell dissociation buffer containing EDTA/EGTA (Invitrogen) to make single cell suspensions. Non-specific binding was blocked by incubation in 5 % mouse serum for 15 min, followed by incubation with
Oregon Green-conjugated anti-Ter119 antibody (a generous gift from Dr. S.-I.
Nishikawa) for 30 min. -galactosidase activity was detected using FluoReporter lacZ ATT GTC AGC AAA-3'. 22 cDNA quantities were normalized to the amount of GAPDH cDNA, which was quantified using Rodent GAPDH Control Reagents (VIC 8 probe, Applied Biosystems).
Gene array analysis
Total RNA from E10.5 wild type and Runx1 -/-yolk sacs was extracted using RNeasy kit, and three same genotype samples were mixed equally. The quality and quantity of the isolated RNA was determined using an Agilent 2100 Bioanalyzer (Agilent Technologies). As previously described, 23 Cy3-or Cy5-labeled cRNA was generated 
Results
Abnormal morphology of Runx1 -/-primitive erythrocytes
To study the role of Runx1 in primitive erythropoiesis, we used a loss-of-function strategy. As reported previously, E10.5 Runx1 -/-embryos were not anemic and were indistinguishable from wild type embryos.
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Runx1
-/-embryos began to hemorrhage in the CNS around E11.5, and died around E12.5. Firstly, to examine whether any morphological defects exist in Runx1-deficient primitive erythrocytes, we isolated peripheral blood from live E12. 
-/-primitive erythrocytes already occurred at E9.5, at the molecular level.
Microarray analysis of RNA prepared from the Runx1 -/-yolk sac
We next compared the gene expression profile of wild-type and Runx1 -/-embryos using microarray analysis to identify potential genes that function downstream of Runx1 in primitive erythropoiesis. For this experiment, we used the E10.5 yolk sac, since this organ at this stage is filled with primitive erythrocytes. We found that the expression of 43 genes was reduced in the Runx1 -/-yolk sac (P < 0.01, Table 1 ). These included at least two genes encoding factors known to be involved in erythropoiesis, EKLF and -hemoglobin stabilizing protein (AHSP).
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Reduced expression of EKLF and GATA-1 in Runx1 -/-embryos Figure 3A ).
To confirm and better visualize the reduced expression of GATA-1 in Runx1 -/-primitive erythrocytes, we took advantage of mice transgenic for a GATA-1 promoter-LacZ hybrid gene construct ( Figure 3B ). We previously reported that a GATA-1 promoter element, 3.9kb upstream from the GATA-1 proximal promoter (IE) exon, is active in primitive but not definitive erythrocytes. 19 Thus, we introduced the GATA-1 promoter-LacZ (IE3.9-LacZ) transgene into Runx1 mutant mice as a surrogate to measure GATA-1 expression in Runx1 -/-primitive erythrocytes.
Consistent with the RT-PCR analysis, expression of -galactosidase from the transgene was reduced in E10.5 Runx1 -/-mice compared to Runx1 +/-mice ( Figure 3C and D). Similar results were obtained in E8.5 ( Figure 3C ) and E11.5 embryos (data not shown). Reduced expression of -galactosidase in Runx1 -/-mice was confirmed by FACS analysis ( Figure 3E and F) , suggesting that GATA-1 expression is dependent upon Runx1 in primitive erythrocytes.
Transgenic rescue of Runx1 -/-primitive erythrocytes
To determine whether erythroid-specific reintroduction of Runx1 rescues the abnormal phenotype of Runx1 -/-primitive erythrocytes, transgenic mice expressing Runx1 under the control of the GATA-1 hematopoietic regulatory domain (G1-HRD, also called IE3.9int, Figure 4A ) 19, 20 were crossed into the Runx1 -/-genetic background.
The expression of GATA-1 was observed in the early erythroid progenitors, and G1-HRD significantly recapitulates the endogenous expression profile of GATA-1 in the erythroid lineage. 19 Therefore, although GATA-1 expression was reduced by approximately 60% in Runx1 -/-genetic background ( Figure 3A) , we assumed that this regulatory domain is suitable for our erythroid-specific rescue experiment. As expected, normal erythrocyte morphology and Ter119 expression were restored in
Runx1
-/-mice carrying the G1-HRD-Runx1 transgene ( Figure 4B-D) . Thus, we conclude that the defect in primitive erythrocytes in Runx1 -/-mice is cell autonomous.
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Discussion
In this study, we demonstrated that Runx1 -/-primitive erythrocytes exhibit some abnormal features. Impairment of primitive erythrocytes has also been observed in mice carrying a knocked-in CBF -MYH11 gene. 30 CBF is a heterodimeric binding partner of Runx, and the fusion protein generated from the CBF -MYH11 gene functions as a dominant negative inhibitor of Runx1 activity. 31 In addition, although data were not shown, Wang and coworkers had noticed subtle abnormalities in the morphology and staining intensity of primitive erythrocytes from Runx1 -/-embryos. 11 These results further support our contention that Runx1 plays a role in primitive erythropoiesis in the mouse embryo.
Although the morphology of Runx1 -/-primitive erythrocytes is not normal, we believe that these erythrocytes are nonetheless able to deliver oxygen to body tissues based on following reasons. First, benzidine staining experiments demonstrated that erythrocytes in Runx1 -/-embryos exhibit nearly normal levels of hemoglobinization ( Figure 2B ). Second, mutant mice lacking GATA-1 (Alas), which exhibit no functional primitive erythrocytes, die around E10.5, 32, 33 indicating that intact primitive erythrocytes are essential for the survival of the embryo after E11. Unlike these latter mice, Runx1-deficient mice die instead around E12.5.
We showed here that expression of GATA-1 is at least partially dependent upon Runx1 expression in primitive erythrocytes ( Figure 3) . It is unknown, however,
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whether Runx1 directly regulates GATA-1 transcription. An interaction or association between Runx and GATA has been observed in other biological systems. Human RUNX1 and GATA-1 physically interact and synergistically activate the megakaryocyte gene in vitro. 34 In the Drosophila blood system, coexpression of the GATA factor, Serpent, and the Runt-related factor, Lozenge, enhances crystal cell overproduction. 35 Interestingly, mutations in GATA-1 were found in the vast majority of Down's syndrome (constitutional trisomy 21) patients with acute megakaryoblastic leukemia (DS-AMKL), and an extra copy of RUNX1 on chromosome 21 has been suspected to be responsible for the increased risk of DS-AMKL. 36 These observations suggest that Runx and GATA factors work cooperatively and may modulate one another's activity in a gene regulatory network.
We have uncovered a previously unrecognized role for Runx1 in mouse primitive erythropoiesis. Runx1 is also expressed during immature stages of definitive erythrocytes. 37 In addition, impairment of definitive erythroid differentiation has been observed in an AML patient with a t(8;21) translocation, which results in the production of an AML1-ETO fusion protein. 38 These observations suggest that Runx1 may play a role in definitive erythropoiesis.
Although there is a report that there is no apparent reduction of the hemoglobin level 
